The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
BIO performs many services for members, but none of them are more visible than the BIO International Convention. The BIO International Convention helps BIO fulfill its mission to help grow the global biotech industry. Profits from the BIO International Convention are returned to the biotechnology industry by supporting BIO programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation.
The key benefits of attending the BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering, exposure to industry though-leaders with over 1,500 education sessions at your fingertips, and unparalleled networking opportunities with 16,000+ attendees from 76 countries.
In addition, we produce BIOtechNOW, an online blog chronicling ‘innovations transforming our world’ and the BIO Newsletter, the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
BIO has a diverse membership that is comprised of companies from all facets of biotechnology. Corporate R&D members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. The majority of our members are small companies 90 percent have annual revenues of $25 million or less, reflecting the broader biotechnology industry. Learn more about how you can save with BIO Membership.
BIO also represents academic centers, state and regional biotech associations and service providers to the industry, including financial and consulting firms.
The first BIO International Convention was held in 1993 and attracted approximately 1,400 attendees. The largest event to date was in Boston, Mass. in 2007, with more than 22,000 attendees. Media coverage has increased as well, from a smattering of trade-press reporters in the early years to more than 400 reporters in recent years. Many of the session topics are focused on perennial themes: raising capital in the venture and public markets; FDA, USDA, and EPA regulation; and patenting trends. Growth of the meeting, and BIO overall, has paralleled that of the young, dynamic industry BIO represents.
The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry. The event features keynotes and sessions from key policymakers, scientists, CEOs, and celebrities. Past speakers include Will Smith, Dr. Bennet Omalu, President George W. Bush, President Bill Clinton, Former Prime Minister of Great Britain and Northern Ireland Tony Blair, Michael J. Fox, Sir Elton John, Her Majesty Queen Noor of Jordan, and General Colin Powell, among many others. The Convention also features the BIO Business Forum (One-on-One Partnering), hundreds of sessions covering biotech trends, policy issues and technological innovations, and the world's largest biotechnology exhibition - the BIO Exhibition.
Did you know that the BIO International Convention was named one of the Top 250 trade shows in the world? Thank you to our exhibitors, sponsors, attendees, speakers and everyone who has supported BIO over the years!